°Ë»ö
ä¿ë
Á¤º¸
    ¼­Ãʱ¸¾à, ÅÂdz¡¤Æø¿ì ÇÇÇØ ¾à±¹ °Ý·ÁÂ÷ ¹æ¹®
    ±â»çÀÔ·Â : 10.10.24 16:57:33
    0 °¡
    ÇÃÄ£Ãß°¡
    ±èÁ¾È¯ ȸÀå, Ãֹ̿µ ºÎȸÀå µî Áö¿ø±Ý¡¤ÄÉÀÍ Àü´Þ




    ¼­Ãʱ¸¾à»çȸ(ȸÀå ±èÁ¾È¯)ÀÌ ÃÖ±Ù Ãß¼® ¿¬ÈÞ Æø¿ì ¹× ÅÂdz °ïÆÄ½º·Î ÇÇÇØ¸¦ ÀÔÀº ¾à±¹µéÀ» ¹æ¹®ÇØ ´ëÇѾà»çȸ Â÷¿ø¿¡¼­ ¸¶·ÃµÈ Áö¿ø±ÝÀ» Àü´ÞÇß´Ù.

    24ÀÏ ±¸¾à»çȸ¿¡ µû¸£¸é ±èÁ¾È¯ ȸÀå°ú Ãֹ̿µ Ãѹ«ºÎȸÀåÀº ÅÂdz ¹× Æø¿ì ÇÇÇØ¸¦ ÀÔÀº ÇØ¸¼Àº¾à±¹, ´Ù¼Ø¾à±¹, ½Å¹ÝÆ÷¾à±¹°ú ³ª¼º¿Â´©¸®, ½Å¿À¾à±¹, ¼­±¤¾à±¹, ÇѼº¸ÞµðÄ®, õ»ç¾à±¹ µîÀ» ¹æ¹®ÇØ À̵éÀ» °Ý·ÁÇß´Ù.

    ±è ȸÀå µîÀº ÇÇÇØ ¾à±¹µéÀ» À§·ÎÇÑ´Ù´Â Â÷¿ø¿¡¼­ ¹Ì¸® ÁغñÇÑ ÄÉÀÍÀ» ÇÔ²² Àü´ÞÇϱ⵵ Çß´Ù.
    X
    AD
    ·Î°ÔÀÎÆû ¸ð¸àÅ͸® À̺¥Æ®Âü¿© ¡æ
    ¹Úµ¿ÁØ ±âÀÚ(pdj30@dailypharm.com)
    ±ÛÀÚÅ©±â ¼³Á¤
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    • Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â
    • [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â
    • ¼­¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â
    • RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â
    • ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â
    • 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â
    • °­¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â
    • º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â
    • °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â
    • Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â
    • º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â
    • Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â
    • Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â
    • [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈ­ÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â
    0/300
     
    ¸ÞÀϺ¸³»±â
    ±â»çÁ¦¸ñ : ¼­Ãʱ¸¾à, ÅÂdz¡¤Æø¿ì ÇÇÇØ ¾à±¹ °Ý·ÁÂ÷ ¹æ¹®